VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Colgate-Palmolive Company vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Colgate-Palmolive Company
CL · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Colgate-Palmolive Company's moat claims, evidence, and risks.
View CL analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 74 / 100 for Colgate-Palmolive Company).
- Segment focus: Colgate-Palmolive Company has 4 segments (43% in Oral Care); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Colgate-Palmolive Company has 2 moat types across 2 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Colgate-Palmolive Company
Oral Care
Oral care products (toothpaste, manual toothbrushes, mouthwash)
Global
Consumers; also dentists and oral health professionals (pharma dental products)
Branded consumer products manufacturer
43%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Colgate-Palmolive Company strengths
Novo Nordisk A/S strengths
Segment mix
Colgate-Palmolive Company segments
Full profile >Oral Care
Oligopoly
Personal Care
Competitive
Home Care
Competitive
Pet Nutrition
Oligopoly
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.